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Introduction {#sec1}
============

RNA localization and local translation play key roles in the assembly, maintenance, and repair of neuronal connections ([@bib15], [@bib27], [@bib32], [@bib56], [@bib72]). Recent genome-wide studies on the axonal transcriptome reveal that thousands of mRNAs are localized to axons ([@bib2], [@bib25], [@bib48], [@bib80]). A consistent but unexpected finding of these studies is the robust enrichment of mRNAs that encode ribosomal proteins (RPs) in axons of a variety of neuron types ([@bib2], [@bib4], [@bib7], [@bib24], [@bib25], [@bib44], [@bib57], [@bib69], [@bib80]). This finding cannot simply be explained by Brownian diffusion of mRNAs from the soma, since several studies showed that these transcripts are significantly enriched in the axon compared to the cell body ([@bib2], [@bib57]), suggesting the presence of mechanisms that selectively target RP-coding transcripts to the axon. Furthermore, recent studies provide evidence that RP-coding mRNAs are robustly translated in retinal ganglion cell (RGC) axons both *in vivo* ([@bib61]) and *in vitro* ([@bib5]), raising the possibility that locally supplied RPs serve to support axonal function.

Axons are long neuronal processes that carry out many vital specific cellular functions far from their cell bodies, including translation, and must therefore maintain their protein synthetic machinery in good order. However, because eukaryotic ribosome assembly is known to occur mainly in the nucleolus ([@bib22], [@bib36], [@bib51]), the physiological function of axonally synthesized RPs in a neuronal subcellular compartment far distant from the nucleus is enigmatic. Recent studies on spinal muscular atrophy (SMA) implicated a potential role for free RPs in the maintenance of ribosomes in axons ([@bib3], [@bib55]). The depletion of the survival motor neuron (SMN) protein, an RNA-binding protein that associates with RP-coding mRNAs ([@bib55]), caused a significant decrease in translation levels of RP-coding mRNAs ([@bib3]). SMN depletion also leads to a 27% reduction in the number of ribosomes in axons ([@bib3]). Although the causal relation remains uncertain, one possibility is that axonally synthesized RPs are used to make integral components of functional ribosomes.

The eukaryotic ribosome is a macromolecular machine composed of 4 ribosomal RNA (rRNA) molecules and ∼80 different RPs. Eukaryotic RPs are shipped into the nucleus for assembly into ribosomal subunits within the nucleolus, although a few ribosomal proteins are added to the ribosome in the cytoplasm, such as Rpl24/eL24, Rpl10/uL16, and Rplp0/uL10 ([@bib49]). A number of previous studies called into question the widely held view of the ribosome as a stable molecular machine whose components remain unchangeable during its lifetime. For example, several RPs in the ribosome have higher turnover rates than other RP components, suggesting the possibility that individual RPs in the ribosome can be replaced by free cytoplasmic RPs ([@bib36], [@bib41], [@bib58]). These studies, together with the robust axonal translation of RPs, prompted us to ask whether axonal ribosomes incorporate locally synthesized RPs to maintain ribosome function far from the cell body.

In this study, we explored roles of axonally synthesized RPs using a range of technical approaches, including live imaging, *in vivo* axon-specific knockdown, and mass spectrometry-based proteomics. We found that RP translation is regulated by a branch-promoting factor, Netrin-1, through a loop structure-forming sequence motif called CUIC, that is shared by ∼70% of RP-coding mRNAs. Isoforms of RP mRNAs with a short 5′ UTR truncated at the CUIC region are highly enriched in axons. Transcriptome and proteome analyses revealed that the structural positions of axonally abundant RPs are biased toward the surface of the ribosome subunits. Live imaging and subcellular proteomic approaches showed that axonally synthesized RPs physically associate with axonal ribosomes in a nucleolus-independent fashion. Furthermore, we show that inhibition of axonal RP synthesis leads to a significant decrease in the level of axonal mRNA translation and severe axon branching defects *in vivo*. These results support the view that ribosome function is maintained by a cytoplasmic pool of locally synthesized RPs in axons.

Results {#sec2}
=======

RP-Coding mRNAs Harbor a Common Loop Structure-Forming Sequence Motif in Their 5′ UTR {#sec2.1}
-------------------------------------------------------------------------------------

To analyze the axonal transcriptome and proteome, we used a well-established method to harvest pure RGC axons from embryonic *Xenopus* eyes grown on microporous transfilters ([Figure S1](#mmc1){ref-type="supplementary-material"}A) ([@bib5], [@bib78]). The intact nature of the eyes permits only the axons, not the dendrites, of RGCs to grow out of the eye (via the optic nerve) onto the transfilter with soma-excluding 1μm pores ([Figure S1](#mmc1){ref-type="supplementary-material"}A). The purity of the axon sample was confirmed by RT-PCR and immunostaining of soma/nuclear factors ([Figure S1](#mmc1){ref-type="supplementary-material"}B) ([@bib5]). Using this pure axon material, we first performed an RNA sequencing (RNA-seq) analysis of RGC axons. Consistent with previous studies ([@bib15]), RPs were robustly enriched in the axonal transcriptome ([Figure 1](#fig1){ref-type="fig"}A). Next, we investigated a potential physiological role of axonal RP synthesis by analyzing our genome-wide translatome data of mouse RGC axons *in vivo* ([@bib61]). The axonal translation of most RP-coding mRNAs peaks during the branching/synaptogenesis stage (postnatal day \[P\] 0.5) and declines thereafter in a synchronous manner ([Figure 1](#fig1){ref-type="fig"}B). The pattern of translational changes of RP-coding mRNAs during the postnatal period (P0.5--P7.5) was significantly different from the other translated mRNAs ([Figure 1](#fig1){ref-type="fig"}B, lower panel), suggesting the presence of a mechanism that co-regulates the synthesis of many different RPs in axons.Figure 1RP-Coding mRNAs Harbor a Common Loop Structure-Forming Sequence Motif in the 5′ UTR(A) Enrichment of GO terms in the *Xenopus laevis* RGC axon transcriptome.(B) Relative abundance (FPKM) of translated mRNAs coding for RPs (red) and other proteins (gray) in the mouse RGC axon (y axis) and retina (x axis), obtained by the Axon-TRAP system *in vivo*. The histogram (lower) shows the distribution of the ratio of abundance of 2 consecutive stages (refinement \[P7.5\]/branching \[P0.5\]). p value: Kolmogorov-Smirnov test between RP coding mRNAs and non-RP mRNAs.(C) Relative position of the CUIC and RNA-secondary structure of 5′ UTRs of mouse RP-coding mRNAs. Each bar represents 5′ UTR sequences and is colored by the predicted secondary structure. The position of CUIC is aligned at center (0 nt) and the x axis indicates the distance from the CUIC motif.(D) Average fraction of double-stranded nucleotides around the CUIC motif in 5′ UTRs of all CUIC-containing mouse genes and RPs (moving average, 7-nt window).(E) The ranking of RBPs that specifically bind to the CUIC motif of RP-coding mRNAs. The heatmap color indicates the specificity score calculated by the formula in the upper panel. The histogram (left) shows the average of the specificity score of each RBP for all CUIC-containing RP mRNAs. Red dots mark eIF3 components, and blue dots mark TIA1 and TIAL1.(F) UCSC Genome browser view of CLIP clusters of eIF3 components on 2 RP-coding mRNAs.

The coordinated axonal RP synthesis led us to infer that RP-coding mRNAs may have a common *cis*-regulatory element(s). A *de novo* motif discovery algorithm ([@bib26]) revealed that ∼70% of RP-coding mRNAs share a 5′ UTR sequence motif, YYYYTTYC ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Since this motif is located immediately (20--80 nt) upstream of the initiation codon of RP-coding mRNAs in most cases (\>90%) ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}D), we called this motif *cis*-element upstream of the initiation codon (CUIC). Gene Ontology (GO) enrichment analysis revealed that not only ribosome-related GO terms but also those linked to neuron morphogenesis are enriched in all CUIC-containing mouse genes ([Figure S1](#mmc1){ref-type="supplementary-material"}E), suggesting a potential role of the CUIC motif in axon projection and branching. Consistent with this, translatome analysis in RGC axons reveals that CUIC-containing transcripts have significantly higher translation levels than those without ([Figure S1](#mmc1){ref-type="supplementary-material"}F). The predicted RNA secondary structure of 5′ UTRs of RP-coding mRNAs shows that the nucleotide region around the CUIC motif tends to form a single-stranded loop, which may allow *trans* factors to recognize this motif ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}G; [Table S1](#mmc2){ref-type="supplementary-material"}). The sequence and the loop structure are well conserved among animal species ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}H).

To explore which RNA-binding proteins (RBPs) associate with the CUIC motif, we analyzed published cross-linking immunoprecipitation (CLIP)-seq datasets in the POSTAR2 database ([@bib79]). In this analysis, we counted the number of CLIP clusters that overlapped with the CUIC region of RP-coding mRNAs for each RBP and normalized them to the total number of clusters on any region of the mRNAs to evaluate the specificity of RBP binding ([Figure 1](#fig1){ref-type="fig"}E). This revealed that components of the eIF3 complex are particularly enriched in the proteins that specifically bind to the CUIC motif of RP-coding mRNAs ([Figures 1](#fig1){ref-type="fig"}E and 1F).

CUIC Motif Is Associated with Alternative 5′ Ends and Netrin-1-Stimulated Translation of Axonal mRNAs {#sec2.2}
-----------------------------------------------------------------------------------------------------

Our analysis of CLIP-seq data also showed that TIA1 and TIAL1 bind with high specificity to the CUIC region ([Figure 1](#fig1){ref-type="fig"}E). Since these proteins were reported to be key factors in 5′ terminal oligopyrimidine tract (5′ TOP) mRNA regulation ([@bib13]), we sought to understand the relation between CUIC and 5′ TOP mRNAs. Although both the CUIC and 5′ TOP motif are a tract of pyrimidine nucleotides in the 5′ UTR, CUIC is always immediately upstream of the initiation codon and is usually distant from the 5′ end, unlike the 5′ TOP sequence, which is always at the 5′ terminal of mRNAs ([@bib43]). Several RP-coding mRNAs contain both the 5′ TOP and CUIC motifs in separate positions ([Figure S2](#mmc1){ref-type="supplementary-material"}A). However, since we found that the mouse expressed sequence tag (EST) showed that the positions of 5′ ends of the CUIC-containing RP mRNAs are highly variable, an interesting possibility is that the alternative 5′ end formed at the CUIC region generates a 5′ TOP-like sequence. To explore this possibility, we analyzed the 5′ end sequence of CUIC-containing mRNAs in our *Xenopus* RGC axon RNA-seq data. Whereas the 5′ ends of CUIC-containing transcripts detected in *Xenopus* whole embryos ([@bib19]) are located upstream (0--300 nt) of the CUIC region in most cases, the 5′ ends of those in the RGC axon sample tended to have short 5′ UTRs that were truncated at the CUIC region ([Figures 2](#fig2){ref-type="fig"}A, 2B, and [S2](#mmc1){ref-type="supplementary-material"}B). This prevalence of short isoforms in axons was validated by 5′ rapid amplification of cDNA ends (RACE) comparing the 5′ end of Rps4x/eS4 transcripts between the RGC axon and the somal (whole-eye) samples ([Figure 2](#fig2){ref-type="fig"}C). Sequencing of the amplified cDNAs showed that the 5′ end of the Rps4x/eS4 short isoform is precisely located at the CUIC region ([Figure 2](#fig2){ref-type="fig"}C). These results suggest that the alternative 5′ end at the CUIC region can generate a 5′ TOP-like sequence in RP-coding mRNAs ([Figure 2](#fig2){ref-type="fig"}B). Since 5′ TOP mRNAs are regulated by the mammalian target of rapamycin (mTOR) pathway ([@bib31]), and the mTOR pathway is required for Netrin-1-mediated local translation ([@bib8]), the CUIC motif could play a crucial role in regulated RP synthesis in the axon. To investigate the relation between Netrin-1 stimulation and CUIC-containing RP mRNAs, we analyzed a proteomics dataset of the cue-induced nascent (newly synthesized) proteome in cultured *Xenopus* RGC axons ([@bib5]). The analysis revealed that RPs are particularly enriched in the group of proteins whose translation is promoted by Netrin-1 (p = 0.0001, enrichment of GO: 0005840) ([Figure S2](#mmc1){ref-type="supplementary-material"}C; [Tables S2](#mmc3){ref-type="supplementary-material"} and [S3](#mmc4){ref-type="supplementary-material"}). Consistent with this result, quantification of the immunofluorescence (QIF) signal showed that Netrin-1 increases the translation of most, but not all, RPs tested in axonal growth cones ([Figures 2](#fig2){ref-type="fig"}D, 2E, [S2](#mmc1){ref-type="supplementary-material"}D, and S2E). We next investigated the effect of the CUIC motif on axonal RP synthesis by performing fluorescence recovery after photobleaching (FRAP) experiments using the fast-folding fluorescent protein Venus, expressed from mRNAs with and without the CUIC motif in the UTR. We tested the UTR of Rps4x/eS4, the RP that shows the greatest increase in axonal translation after Netrin-1 stimulation ([Figures 2](#fig2){ref-type="fig"}D, 2E, and [S2](#mmc1){ref-type="supplementary-material"}C). While no significant difference was observed in the FRAP signal in basal conditions over the 10-min period of imaging, the addition of Netrin-1 elicited a significantly higher FRAP signal with the full-length 5′ UTR reporter compared to the CUIC-deleted or 5′ UTR-deleted reporter constructs ([Figures 2](#fig2){ref-type="fig"}F and 2G), indicating a higher translation rate of the CUIC-containing mRNA. The inhibition of translation with anisomycin abolished this difference ([Figure S2](#mmc1){ref-type="supplementary-material"}F). Consistent with these FRAP results, independent experiments using a single-molecule translational imaging approach ([@bib30], [@bib64], [@bib67]) that captures individual translation events in real-time revealed a significantly higher number of translation events with the CUIC-containing reporter, compared to the CUIC-deleted reporter, in Netrin-1-stimulated axonal growth cones ([Figure 2](#fig2){ref-type="fig"}H). These data provide evidence that the CUIC motif is, at least partially, responsible for the Netrin-1-induced axonal translation of RPs.Figure 2CUIC Motif Is Involved with Alternative 5′ End and Netrin-1-Stimulated Translation of Axonal RP mRNAs(A) Plot showing the difference of the position of 5′ terminal of CUIC-containing mRNAs between the axon and the whole embryo. The x axis indicates the relative position of 5′ terminal compared to CUIC.(B) Diagram showing 2 isoforms of the CUIC-containing mRNA with alternative 5′ ends and the 5′ TOP mRNA.(C) Diagram (left), gel image (middle), and Sanger sequencing result (right) of 5′ RACE products of Rps4x/eS4 mRNAs in axon and eye samples.(D and E) Representative images (D) and quantification of quantitative immunofluorescence (QIF) (E) for Rps14/uS11 (n = 42, control; 59, CHX; 66, Netrin-1; 64, Netrin-1 + CHX) and Rps4x/eS4 (n = 59, control; 50, CHX; 70, Netrin-1; 44, Netrin-1 + CHX) in RGC growth cones with or without Netrin-1 (5 min)/cycloheximide (CHX) treatment (bars, average with 95% confidence interval \[CI\], Mann-Whitney *U* test compared to the control, ^∗∗∗^p ≤ 0.001, ^∗^p ≤ 0.05). Scale bar, 5 μm.(F and G) Plots (F) and representative images (G) of relative fluorescence recovery of Venus reporter constructs after photobleaching (error bar, SEM) in RGC growth cones. ^∗∗∗^p \< 0.0001; 2-way ANOVA comparing full-length UTRs (n = 8) with Del-motif (n = 12). Scale bar, 2 μm.(H) Moving average (20 s window) of the count of detected translation events per unit area per second with the Netrin-1 stimulation in single-molecule translation imaging. p value: Mann-Whitney *U* test between full-length UTRs (n = 11) and Del-motif (n = 12) using the total count in each growth cone.

Surface Components of the Ribosomal Subunits Are Enriched in the Axoplasm {#sec2.3}
-------------------------------------------------------------------------

The coordinated regulation of numerous axonally synthesized RPs suggests that they may have a common ribosome-related function rather than a disparate variety of extra-ribosomal roles ([@bib71]) in axons. However, since most ribosomal proteins are thought to be assembled into ribosomes exclusively in the nucleolus, it seemed puzzling that ribosomal proteins are synthesized in the distal axon, far away from the nucleolus ([@bib22]). To test the possibility that the retrograde transport of axonally synthesized RPs allows their assembly into ribosomes in the nucleolus, we focused on the abundance of RPs outside of ribosomes (free cytoplasmic RPs) in the distal axon. Robust axonal RP translation should result in the accumulation of free RPs in the axon, unless these are retrogradely transported toward the soma or quickly degraded. To detect free RPs in the axon, we performed sucrose density gradient fractionation on pure-axon lysates, generated using Boyden chambers, as well as on whole-brain lysates ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). Mass spectrometry analysis of the fractionated samples showed a robust accumulation of free RPs in ribosome-free fractions of the axon lysate, whereas RPs were strongly depleted in ribosome-free fractions of the whole-brain lysate ([Figure S3](#mmc1){ref-type="supplementary-material"}D), suggesting that axonally translated RPs have function(s) in the axon rather than in the nucleolus.

To evaluate whether axonally translated RPs are involved in ribosomal function, we focused on the position of these RPs in the ribosome structure. We reasoned that if the axonally translated RPs are used to replace/repair components of the ribosome, the position of these RPs may be biased to the surface of the ribosome because RPs that penetrate deeply into the rRNA core of ribosomal subunits are less likely to be replaced or detached. To address this, we performed an unbiased classification of RPs (surface or core/penetrated) based on their structural position in the human 80S ribosome structure ([@bib45]). For each RP, we assigned an interface-index score based on the fraction of residues that interface with rRNA by using the PyMOL function InterfaceResidues (<https://pymolwiki.org/index.php/Main_Page>). RPs with a high interface-index score (high fraction of rRNA interface residues) tend to be located deep in the ribosome core or have long tails that penetrate into the core ([Figures 3](#fig3){ref-type="fig"}A and 3B). We found that the group of RPs whose mRNAs are abundant in the axon (FPKM \> 100, 61 RPs) had a significantly lower interface-index average (0.42) than the less abundant (FPKM \< 100) group (0.57, Kolmogorov-Smirnov test, p = 0.014) ([Figure 3](#fig3){ref-type="fig"}C). Consistently, RPs with high interface-indices (\>0.6; [Figure 3](#fig3){ref-type="fig"}B) were significantly depleted from the abundant group (5.0-fold depletion, Fisher's exact test, p = 0.0016) ([Figure 3](#fig3){ref-type="fig"}C). Although label-free quantification (LFQ) of mass spectrometry is a less robust quantitative method compared to RNA-seq, we observed a similar trend in which high interface-indices (\>0.6) were significantly depleted from the group of RPs with high abundance (LFQ abundance score \> 1) in the axonal ribosome-free fraction ([Figure S3](#mmc1){ref-type="supplementary-material"}E). These results indicate that the axon, but not the cell body, contains a large cytoplasmic pool of extra-ribosomal RPs that are biased to occupy superficial structural positions in the ribosome and suggest the possibility that surface components of axonal ribosomes may be replaced by these cytoplasmic free RPs in axons.Figure 3Structural Positions of RPs Encoded by Axonally Localized mRNAs Are Surface Biased(A) Formula of interface-index (upper) and a partial structure of the ribosome, generated with PyMOL, showing the relation between RP position and interface-indices.(B) Human 80S ribosome structure, generated with PyMOL, showing the position of all RPs that are classified based on the interface-index.(C) Ranking of abundance (average FPKM) of RPs coding mRNAs (n = 2) and interface-index scores of RPs (more blue = higher, more red = lower).

Axonally Synthesized RPs Become Physically Associated with Ribosomes {#sec2.4}
--------------------------------------------------------------------

To investigate the interaction of axonally synthesized RPs with the ribosome, we first performed an *in situ* proximity ligation assay (PLA), a technology capable of detecting the close physical association between 2 molecules (\<400 Å) ([@bib77]). We carried out metabolic labeling of newly synthesized proteins with [l]{.smallcaps}-azidohomoalanine (AHA) in severed axons ([@bib18]). After biotin conjugation to AHA via "click" chemistry, we performed PLA to detect the association between axonally synthesized proteins (biotin antibody) and ribosomes, using the anti-rRNA antibody Y10B ([@bib1]) ([Figure 4](#fig4){ref-type="fig"}A). As eukaryotic ribosomes are 250--300 Å in diameter, the proximity between the AHA-labeled RPs and the rRNA is expected to generate a PLA signal if axonally synthesized RPs are incorporated into axonal ribosomes ([Figure 4](#fig4){ref-type="fig"}A). To eliminate the detection of elongating nascent AHA-labeled polypeptide chains, axons were treated with 200 μM puromycin, which releases growing polypeptide chains from the ribosome ([@bib11], [@bib46]) before the sample fixation. We observed a clear PLA signal in the axons, which was abolished by anisomycin treatment ([Figures 4](#fig4){ref-type="fig"}B and 4C). We also found that the PLA signal was significantly higher in Netrin-1-stimulated axons than in unstimulated axons ([Figures 4](#fig4){ref-type="fig"}B and 4C), which is consistent with the results that Netrin-1 promotes axonal RP synthesis ([Figures 2](#fig2){ref-type="fig"} and [S2](#mmc1){ref-type="supplementary-material"}). While these proximity-based results do not rule out the association of newly synthesized non-RP factors with the surface of axonal ribosomes, they demonstrate that some proteins synthesized in response to Netrin-1 in axons become closely associated on-site with ribosomes and support the idea that newly synthesized RPs join axonal ribosomes.Figure 4Axonally Synthesized RPs Co-localize with Ribosome-Containing Granules(A) Experimental workflow and a diagram describing the positional relation of each protein/probe in the rRNA-FUNCAT-PLA experiments.(B and C) Representative images (B) and plots for the number of PLA puncta in each condition (C) detected in the axon (bars, average with 95% CI, Mann-Whitney *U* test, ^∗∗∗^p ≤ 0.001). Scale bar, 5 μm.(D) Experimental workflow of the Venus + Cy5-UTP FRAP experiments (upper). Live imaging of Cy5-UTP (magenta) and UTR-Rps4x-Venus fusion or UTR-Venus (green) reporter before and 0, 5, and 10 min after photobleaching of the Venus (green) fluorescence. The yellow arrowheads indicate the sites of co-localization, and the white lines indicate the outlines of axons. Scale bar, 2 μm.(E) Plot showing Pearson's correlation coefficient of pixel intensities between Cy5-UTP signals and recovered Venus signals (Venus-Rps4x \[n = 8\] or Venus-only \[n = 12\]). Bars, average with SEM, Mann-Whitney *U* test, ^∗^p ≤ 0.05.

To look specifically at the question of whether newly synthesized RPs themselves co-localize with ribosomes, we used a modified FRAP approach and dual-channel time-lapse imaging in live axons. We have previously shown that blastomere-injected labeled UTP is incorporated predominantly into ribosomal RNAs ([@bib75]) and that translation takes place on these Cy5-UTP granules in live retinal axons ([@bib75], [@bib11]). Therefore, we used Cy5-UTP as a live reporter of ribosome/RNA-rich granules. We also introduced a cDNA encoding Venus-Rps4x/eS4, an RP fusion protein. We observed that bright fluorescent puncta of Venus-Rps4x/eS4, but not the Venus-only control, co-localize and co-move with Cy5 fluorescent puncta, confirming that Cy5-UTP labels ribosome/RNA-rich granules ([Figures 4](#fig4){ref-type="fig"}D and [S4](#mmc1){ref-type="supplementary-material"}). Next, to visualize the newly synthesized Venus proteins, we performed photobleaching of the Venus fluorescence with 488-nm laser light and then examined the co-localization between Cy5-UTP fluorescence and the recovered Venus signal. Before photobleaching, we cut the axons to exclude the signal of Venus proteins transported from the soma. Immediately post-cut and before photobleaching, we added Netrin-1 to stimulate axonal Rps4x/eS4 synthesis. Time-lapse imaging revealed that the signal of recovered (axonally synthesized) Venus-Rps4x/eS4 protein, but not of control Venus protein, exhibited sustained co-localization with Cy5-labeled RNA after photobleaching in severed somaless RGC axons ([Figures 4](#fig4){ref-type="fig"}D and [S4](#mmc1){ref-type="supplementary-material"}). This result was further confirmed by a spatial correlation analysis, in which the correlation (Pearson's correlation coefficient) of the pixel intensities between recovered Venus-Rps4x and Cy5-UTP signals was significantly higher than that between Venus-only control and Cy5-UTP ([Figure 4](#fig4){ref-type="fig"}E).

To obtain biochemical evidence for the axonal incorporation of axonally synthesized RPs into axonal ribosomes, we combined axon-pSILAC ([@bib5]) with axonal ribosome purification ([Figure 5](#fig5){ref-type="fig"}A). In this method, we labeled newly synthesized proteins with heavy amino acids for 3 h in somaless axons cultured in a Boyden chamber. Together with heavy amino acids, Netrin-1 was added to stimulate the axonal translation of RPs. After the lysis of labeled axons, axonal ribosomes were purified using a sucrose cushion and ultracentrifugation, followed by the identification of newly synthesized proteins with mass spectrometry ([Figure 5](#fig5){ref-type="fig"}A). To obtain sufficient axonal material, ∼2,000 eyes were cultured for each sample. Mature 18S rRNA was detected in both somas and axons, whereas the pre-rRNA, which is present only in the nucleolus, was detected only in somata ([Figure 5](#fig5){ref-type="fig"}B), confirming that there was no contamination of the axon samples with somata/nuclei in these experiments. We used the same method as a control sample on isolated eyes that were treated with heavy amino acids for 48 h. Mass spectrometry analysis revealed that ∼93% of all detected proteins in the axonal ribosome samples were in a single gene-network cluster that includes RPs and ribosome-interacting proteins, validating the ribosome purification procedure ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Mass spectrometry detected a number of labeled (i.e., axonally synthesized) RP peptides in the axonal ribosome samples. The ratios of labeled/unlabeled RP peptides in the axonal ribosome samples were highly variable among RPs, whereas relatively constant ratios of labeled RPs were observed in whole cells (the eye sample) ([Figure S5](#mmc1){ref-type="supplementary-material"}B). These results not only show that locally synthesized RPs physically associate with ribosomes in the axon but they also exclude the possibility that the detection of labeled RPs in the axonal ribosome samples is caused by contamination of our axon sample with cell bodies. We still detected labeled RP peptides in axons even when the axon lysate was treated with RNase A/T1 and puromycin, which dissociate mRNA-binding proteins, including the poly(A)-binding protein from the purified ribosomes ([Figures S5](#mmc1){ref-type="supplementary-material"}C--S5F). This result suggests that the detection of these labeled RP peptides was not due to the binding of free extra-ribosomal RPs to the ribosome-bound mRNAs. The puromycin step also ensured that we were not detecting growing polypeptide chains, which is consistent with the fact that the position of heavy labeled RP peptides was not biased toward the N terminus ([Figure 5](#fig5){ref-type="fig"}C). Analysis of our mouse *in vivo* axonal translatome showed that most (85%) of the labeled RPs detected in the axonal ribosome samples are axonally synthesized during the branching stage of RGC axon development ([Figure 5](#fig5){ref-type="fig"}D). Most (91%) of these are not deeply penetrated RPs ([Figure 3](#fig3){ref-type="fig"}B) in the ribosome structure (2.2-fold depletion of interface-index \< 0.6) ([Figures 5](#fig5){ref-type="fig"}D and 5E). Although the subcellular nature of our material prohibited the use of approaches to resolve whether the axonally synthesized RPs are actually embedded in the ribosome in their normal positions, these results support the idea that locally synthesized RPs physically associate with axonal ribosomes in a nucleolus-independent manner.Figure 5Axonally Synthesized RPs Physically Interact with the Ribosome in a Nucleolus-Independent Manner(A) Experimental strategy of axon purification, SILAC labeling, and axonal ribosome purification.(B) Diagram and gel image of RT-PCR detection of mature 18S rRNA and pre-rRNA.(C) Cumulative percentage of the relative position of labeled peptides detected in axonal (cyan) and eye (red) ribosome samples.(D) List of RPs whose labeled peptides were detected in the axonal ribosomes. The heatmap shows the translation levels of RPs in 3 different developmental stages of *in vivo* mouse RGC axons.(E) Human 80S ribosome structure with indication of the RPs whose labeled peptides were detected in the axonal ribosomes. The colors of the squares represent the interface-index of each labeled RP (see [Figure 3](#fig3){ref-type="fig"}).(F) Immunostaining of ribosomal assembly factors and a secondary antibody-only control in cultured *Xenopus laevis* RGC axons. Scale bar, 5 μm.

To explore the possibility that nucleolar ribosome assembly factors mediate the axonal interaction between RPs and ribosomes ([@bib35]), we searched our *Xenopus* RGC axon proteome data ([@bib5]) for proteins whose mouse ortholog genes were annotated with the GO terms "nucleolus" (GO: 0005730) or "ribosome assembly" (GO: 0042255). We found that 12.6% (124 of 982) of proteins with these GO terms were detected in our axon sample, some of which were confirmed by immunostaining ([Figure 5](#fig5){ref-type="fig"}F). Many of these factors were detected in the axons of different types of neurons, such as mouse callosal axons ([@bib53]) and axons of rat cortical neurons ([@bib10]), suggesting that the functions of these factors are conserved among these neuron types ([Figure S5](#mmc1){ref-type="supplementary-material"}G).

Locally Synthesized Rps4x/eS4 Is Required to Maintain Ribosome Function in Axons {#sec2.5}
--------------------------------------------------------------------------------

Next, we focused on the functional interaction between axonally synthesized RPs and axonal ribosomes. To ask whether local RP synthesis affects the protein synthesis activity of axonal ribosomes, we performed axon-specific inhibition of RP synthesis using a microfluidic chamber that isolates the axonal compartment from the cell body compartment ([@bib68]). Taking advantage of the fluidic isolation of the chamber ([@bib68]), we delivered a FITC-conjugated morpholino only into the axonal compartment to inhibit axonal RP synthesis ([Figure 6](#fig6){ref-type="fig"}A) for three RPs---Rps3a/eS1, Rps4x/eS4, and Rpl5/uL18---all of which are synthesized/translated robustly in RGC axons ([@bib5], [@bib61]). Although we could not find a significant effect on axonal protein synthesis after *rps3a* (eS1) or *rpl5* (uL18) morpholino delivery, we found that the *rps4x* (eS4) morpholino significantly reduced the level of proteins labeled with puromycin, a structural analog of aminoacylated-tRNA which labels newly synthesized proteins ([@bib63], [@bib70]) in axonal growth cones ([Figures 6](#fig6){ref-type="fig"}B--6D, 6F, [S6](#mmc1){ref-type="supplementary-material"}C, and S6D). The *rps4x* morpholino decreases the Rps4x/eS4 protein level only in the axons but not in the somata ([Figures 6](#fig6){ref-type="fig"}D, 6F, [Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). In addition, we found that neither the level of Rpl17/uL22 nor the level of 18S rRNA was changed by the *rps4x* morpholino ([Figures 6](#fig6){ref-type="fig"}E--6G), suggesting that the decreased level of newly synthesized proteins in axons is not caused by a reduced number of axonal ribosomes. These data show that the inhibition of axonal *rps4x/eS4* translation decreases the level of translation activity in the axon, suggesting a crucial role for axonally synthesized Rps4x/eS4 in axonal ribosome function.Figure 6Locally Synthesized Rps4x/eS4 Is Required to Maintain Ribosome Function in Axons(A) Diagram (left) and image of RGC axons after FITC-morpholino introduction in a microfluidic chamber.(B--F) Images (B, D, and E) and QIF plots (bars, average, 95% CI, and distribution of normalized levels) (C and F) of Rps3a/eS1, Rps4x/eS4, Rpl17/uL22, and puromycin immunostaining in axons treated with control morpholinos (Cont.) or with morpholinos against *rps3a* (eS1) (B and C) or against *rps4x* (eS4) (D--F), with Welch t test (^∗^p = 0.030, C; 0.015, F; ^∗∗∗^p = 0.0004; n.s., not significant).(G) qRT-PCR quantification, normalized to control MO, of 18S rRNA in axonal samples treated with control or *rps4x* (eS4) morpholinos (n.s., not significant in Mann-Whitney *U* test).

Axonal Synthesis of Rps4x/eS4 Is Crucial for Axon Branching *In Vivo* {#sec2.6}
---------------------------------------------------------------------

Next, we asked whether newly synthesized RPs incorporated into axonal ribosomes are critical for axon development *in vivo*. Our analysis showed that the axonal synthesis of RPs is enhanced by Netrin-1, which promotes axon branching ([@bib16], [@bib39]), and it peaks at the branching stage in mouse RGC axons *in vivo* ([Figure 1](#fig1){ref-type="fig"}B). A previous study demonstrated that exposed intact brains treated acutely with protein synthesis inhibitors show a reduction in axonal branching dynamics in the optic tectum ([@bib75]). Thus, our finding that Rps4x/eS4 knockdown inhibits axonal protein synthesis ([Figure 6](#fig6){ref-type="fig"}) prompted us to test whether the local synthesis of Rps4x/eS4 is essential for the normal branching of axons. Taking advantage of an *in vivo* system to visualize single *Xenopus* RGC axons ([@bib74], [@bib75]), we inhibited Rps4x/eS4 synthesis by morpholino-based knockdown ([Figure 7](#fig7){ref-type="fig"}A). *In vivo* electroporation of *rps4x* morpholino into stage 28 eyes significantly reduced the number, length, and complexity of RGC axon branches in the optic tectum at stage 45 ([Figures 7](#fig7){ref-type="fig"}A--7D and [S7](#mmc1){ref-type="supplementary-material"}A--S7C). These branching phenotypes were rescued by a morpholino-resistant *rps4x* cDNA with full-length UTRs, but not by an *rps4x* cDNA lacking either the entire 5′ UTR or the CUIC motif, suggesting that the CUIC-mediated regulation of Rps4x/eS4 synthesis is crucial for axon branching ([Figures 7](#fig7){ref-type="fig"}B--7D and [S7](#mmc1){ref-type="supplementary-material"}A--S7C). We next investigated the role of Rps4x/eS4 synthesis in the dynamics of axon branching. We first performed *in vivo* live imaging of axons after morpholino electroporation into the eye at stage 28 ([@bib75]). In control embryos at stages 41--43, we observed a significant bias in the addition over the removal of filopodia and branches, in agreement with previous work showing that this bias helps to build arbor complexity ([@bib75]). Inhibition of Rps4x/eS4 synthesis in RGCs abolished this bias. In addition, the numbers of filopodia and branches being added and removed were both reduced after *rps4x* knockdown ([Figures 7](#fig7){ref-type="fig"}E and [S7](#mmc1){ref-type="supplementary-material"}D).Figure 7Axonal Translation of Rps4x/eS4 Is Crucial for Axon Branching *In Vivo*(A) Experimental workflow (upper) for eye electroporation and live image acquisition of axon branches/arbors. Dual promoter constructs (lower) used for rescue conditions.(B) Lateral view of a single *in vivo* RGC axon in the tectum with color-coded images of axon shaft (white), primary (red), secondary (blue), and tertiary (yellow) branches.(C and D) Average, 95% CI, and distribution of total branch length per axon (C) and axon complexity index (ACI; see [Figure S7](#mmc1){ref-type="supplementary-material"}B for formula) (D) in the embryos electroporated with the morpholino/rescue constructs (1-way ANOVA with 2-stage step-up method of Benjamini, Krieger, and Yekutiei multiple comparisons test); n = 21 (Cont. MO), 47 (MO), 21 (MO + WT), 25 (MO + del-5′ UTR), and 37 (MO + del-CUIC).(E--G) Experimental workflow for each knockdown (KD) experiment (left) and quantification (right) of *in vivo* axon branching in control MO^−^ and rps4x MO^+^ axons after eye electroporation (whole-cell KD) (n = 12, Cont.; 20, Rps4x) (E) and tectum electroporation at stages 41--43 (axonal KD) (middle, n = 14, Cont.; 19, Rps4x) (F), and at stages 35--38 (tectum KD) (lower, n = 10, Cont.; 15, Rps4x) (G). Images (middle panel) show a merged overlay of 3 time points (0, 5, and 10 min in blue, red, and green, respectively). Line graphs (right) show the number of added/removed branches/filopodia (paired and unpaired t test, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001; n.s., not significant).

To test whether these phenotypes were caused by the inhibition of local axonal rather than somal translation of *rps4x*, we delivered the *rps4x* morpholino directly into arborizing RGC axons in the tectum by electroporation at stages 41--43 ([Figure 7](#fig7){ref-type="fig"}F) ([@bib77]). To eliminate the possibility that the intracellular diffusion of the morpholino affects somal ribosome biogenesis and the number of ribosomes in the RGC axon, we physically removed the eye, which contains the RGC cell bodies, before morpholino delivery ([Figure 7](#fig7){ref-type="fig"}F) ([@bib75]). Similar to the global inhibition of *rps4x* translation in RGCs, local inhibition of axonal *rps4x* translation abolished the addition/removal bias and reduced the number in both filopodia and branches ([Figures 7](#fig7){ref-type="fig"}F and [S7](#mmc1){ref-type="supplementary-material"}E). To evaluate the extent of secondary effects due to morpholino-electroporated tectal cells, we delivered the morpholino locally into the tectum before the arrival of RGC axons (stages 35/36--37/38) and subsequently visualized the branching dynamics of axons after tectal entry at stages 41--43. No significant differences were observed in branching dynamics, indicating that the inhibition of Rps4x/eS4 synthesis in tectal cells is not responsible for the observed branching defects in RGC axons ([Figures 7](#fig7){ref-type="fig"}G and [S7](#mmc1){ref-type="supplementary-material"}F). These results indicate that the CUIC-mediated axonal synthesis of Rps4x/eS4 is critical for the proper arbor development of RGC axons *in vivo* ([Figure S7](#mmc1){ref-type="supplementary-material"}G).

Discussion {#sec3}
==========

Our results provide multiple independent lines of evidence that are consistent with the hypothesis that locally synthesized RPs in RGC axons are incorporated into axonal ribosomes and are required to maintain axonal ribosome function and normal neuronal developmental processes. Since the distal regions of axons are far away from their somata, our findings suggest the possibility that they have adopted a nucleolus-independent mechanism for the on-site repair and/or modification of their ribosomes through the local supply of newly synthesized RPs. Since we could not detect 18S pre-rRNA in axons ([Figure 5](#fig5){ref-type="fig"}B), it is unlikely that *de novo* assembly of ribosomes takes place in axons. A more plausible hypothesis is that free, extra-ribosomal RPs in axons are incorporated into pre-existing ribosomes in the axon through the replacement or addition of components. This model is consistent with recent proteomics and cryoelectron microscopy studies, which showed the presence of ribosomes lacking specific RP components in eukaryotic cells ([@bib60], [@bib62], [@bib58]). It seems possible that axonal RP synthesis plays an important role in ribosome maintenance, particularly for the surface ribosomal components that may be prone to damage ([Figures 3](#fig3){ref-type="fig"} and [S3](#mmc1){ref-type="supplementary-material"}). It is also possible, however, that it modifies the ribosomal composition to generate "specialized'' ribosomes ([@bib23], [@bib34], [@bib60], [@bib76]), which are tuned to preferentially translate specific mRNAs that regulate axon function.

We found that free extra-ribosomal RPs are enriched in axons compared to the whole cell ([Figure S3](#mmc1){ref-type="supplementary-material"}). This may partly explain the much higher frequencies of the ribosomal incorporation of newly synthesized RPs in Netrin-1-stimulated axons ([Figure S5](#mmc1){ref-type="supplementary-material"}B) than those predicted from previous turnover studies performed on whole cells ([@bib17], [@bib36]). As Netrin-1-induced axonal RP synthesis may significantly increase the concentration of free RPs in axons, it may also elicit a transient increase in ribosome incorporation of newly synthesized RPs in axons ([Figure 5](#fig5){ref-type="fig"}). An important question related to this is whether the ribosomal incorporation of RPs in axons needs any catalytic activity of *trans*-acting auxiliary factors. In prokaryotes, a factor-free *in vitro* assembly of functional ribosomal subunits has been successfully demonstrated by bringing together purified rRNAs and RPs ([@bib54], [@bib65]), but this has not yet been reported in eukaryotes. Accumulating evidence suggests that a large number of non-ribosomal factors (\>200) and small nucleolar RNAs are involved in the *de novo* ribosome assembly in eukaryotic cells, but most of these factors are related to rRNA processing or transport of RPs/pre-ribosomes, while only a few factors have been demonstrated to support the incorporation of RPs ([@bib35]). We found that surface components of the ribosomal subunits are enriched in the axons. The binding of RPs to the surface of the ribosome may therefore be a simpler and different process compared to *de novo* ribosome biogenesis, which comprises the processing and folding of the pre-rRNA and its sequential assembly with deeply embedded ribosomal proteins. It is also possible that some ribosome assembly factors have roles in the axonal incorporation of some RPs. We detected a considerable number of ribosome assembly factors in the axon, although we have not identified any axonal function for these factors. To fully understand the mechanisms underlying axonal RP incorporation, further work on the axonally detected ribosome assembly factors is needed.

We identified a motif called CUIC, which is a form of pyrimidine-rich element (PRE) in the region immediately upstream of the initiation codon of many axonally translated RP mRNAs. It is known that the 5′ TOP sequence plays an important role in the translational control of mRNAs, including RP-coding mRNAs, downstream of the mTOR signaling pathway ([@bib37]). We showed that alternative short isoforms of RP-coding transcripts truncated at the CUIC region are highly enriched in the axon, suggesting the possibility that CUIC can function as a 5′ TOP-like sequence for these short isoforms in axons. This finding may provide an integrated explanation for functions of the 5′ TOP motif and other previously reported pyrimidine-rich sequences, such as the pyrimidine-rich translational element (PRTE) ([@bib29]). Our analysis using previous CLIP-seq studies revealed that, in addition to the eIF3 components, TIA1 and TIAL1, proteins involved with N6-methyladenosine (m6A) methylation (RBM15 and RBM15B) and the recognition of m6A (YTHDF1, YTHDF2, and YTHDC1) ([@bib50]) are specifically associated with the CUIC region ([Figure 1](#fig1){ref-type="fig"}E). Since a recent study reported that an m6A in the 5′ UTR directly binds eIF3, which is sufficient to recruit the 43S complex to initiate translation in a cap-independent manner ([@bib42]), RNA methylation at regions surrounding the CUIC motif core sequence and the subsequent recruitment of the eIF3-43S complex may be involved in the CUIC-mediated axonal translation. Since CUIC is located immediately upstream of the initiation codon, one interesting possibility is that CUIC changes the distance between the 5′ end and the initiation codon through alternative 5′ end formation, affecting the positional relation among initiation factors and ribosomes on the mRNA, which in turn may affect the speed or reliability of translation in response to a signal.

In this study, we uncovered crucial functions of locally synthesized Rps4x/eS4 in axonal mRNA translation and in proper axon branching *in vivo*. Although we cannot exclude the possibility that some unknown extra-ribosomal function of Rps4x/eS4 is responsible for the axon branching phenotype, we propose that the intra-ribosomal function of Rps4x/eS4 is more likely to explain the phenotype observed after axonal inhibition of Rps4x/eS4 synthesis, since several lines of evidence suggest that the process of axon branching is highly dependent on local translation. A previous study showed that RNA granules dock at sites of branch emergence and invade stabilized branches and that acute inhibition of axonal translation by protein synthesis inhibitors and downregulation of the eIF2α pathway cause a very similar axon branching defect as observed after Rps4x/eS4 knockdown ([@bib6], [@bib75]). Furthermore, our previous analysis of the developmental changes of the axonal translatome ([@bib61]) showed that the number of axonally translated mRNAs is highest during branching stages, when synapses are being formed. A recent proteomic study showed that Rps4x/eS4 is the most significantly sub-stoichiometric among all of the RPs in polysomal ribosomes of eukaryotic cells ([@bib62]), suggesting an interesting possibility that, compared to Rps4x/eS4-containing ribosomes, Rps4x/eS4-deficient ribosomes have less translation elongation activity, which may cause a polysomal "traffic jam" on the mRNA ([@bib9]). These results suggest the possibility that axonal RP translation induced by Netrin-1 and the CUIC motif may make axonal ribosomes competent for the extensive protein synthesis needed for axon arborization and synaptogenesis ([Figure S7](#mmc1){ref-type="supplementary-material"}G). Collectively, our findings suggest that ribosomes may be dynamic structures in axons, exchanging/repairing components in response to extrinsic signals. Further studies are needed to provide a fuller understanding of how RP mRNA translation in axons contributes to fundamental processes that establish and/or maintain neural circuits.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Rabbit polyclonal anti-Rps4xProteintechCat\#14799-1-AP; RRID: [AB_2238567](nif-antibody:AB_2238567){#intref0015}Rabbit polyclonal anti-Rpl17ProteintechCat\#14121-1-AP; RRID: [AB_2253985](nif-antibody:AB_2253985){#intref0020}Rabbit polyconal anti-Rps14AbcamCat\#ab174661Mouse monoclonal anti-Rpl19AbcamCat\#ab58328; RRID: [AB_945305](nif-antibody:AB_945305){#intref0025}Mouse monoclonal anti-Rps23AbcamCat\#ab57644; RRID: [AB_945314](nif-antibody:AB_945314){#intref0030}Rabbit polyclonal anti-Rps3aProteintechCat\#14123-1-AP; RRID: [AB_2253921](nif-antibody:AB_2253921){#intref0035}Mouse monoclonal anti-Neurofilament ADSHBCat\#3A10; RRID: [AB_531874](nif-antibody:AB_531874){#intref0040}Rabbit polyclonal anti-Rpl39AbcamCat\#ab74740; RRID: [AB_1524345](nif-antibody:AB_1524345){#intref0045})Rabbit polyclonal anti-Rps12ProteintechCat\#16490-1-AP; RRID: [AB_2146233](nif-antibody:AB_2146233){#intref0050}Rabbit monoclonal anti-Gtpbp4AbcamCat\#ab92342; RRID: [AB_2049721](nif-antibody:AB_2049721){#intref0055}Mouse monoclonal anti-Npm1OrigeneCat\#BM5524; RRID: [AB_1008764](nif-antibody:AB_1008764){#intref0060}Rabbit polyclonal anti-Abce1AbcamCat\#ab32270; RRID: [AB_722514](nif-antibody:AB_722514){#intref0065}Rabbit polyclonal anti-β-actinAbcamCat\#ab8227; RRID: [AB_2305186](nif-antibody:AB_2305186){#intref0070}Rabbit polyclonal anti-β-cateninSigma-AldrichCat\#C2206; RRID: [AB_476831](nif-antibody:AB_476831){#intref0075}Mouse monoclonal anti-puromycin, clone 12D10Sigma-AldrichCat\#MABE343; RRID: AB_2566826Mouse monoclonal anti-ribosomal RNA (Y10B)AbcamCat\#ab171119Rabbit monoclonal anti-biotinCell SignalingCat\#5597; RRID: [AB_10828011](nif-antibody:AB_10828011){#intref0080}Goat anti-rabbit Alexa Fluor 568AbcamCat\#ab150117; RRID: [AB_2688012](nif-antibody:AB_2688012){#intref0085}Goat anti-mouse Alexa Fluor 594AbcamCat\#ab150080; RRID: [AB_2650602](nif-antibody:AB_2650602){#intref0090}Mouse monoclonal anti-puromycin, clone 12D10, Alexa Fluor 647 ConjugateSigma-AldrichCat\#MABE343-AF647Goat anti-mouse HRPAbcamCat\#ab6789; RRID: [AB_955439](nif-antibody:AB_955439){#intref0095}Goat anti-rabbit HRPAbcamCat\#ab97080; RRID: [AB_10679808](nif-antibody:AB_10679808){#intref0100}**Bacterial and Virus Strains**BioBlue Chemically Competent CellsBiolineCat\#BIO-85037**Chemicals, Peptides, and Recombinant Proteins**AHA (L-Azidohomoalanine)ThermoFisherCat\#C10102Leibovitz's L-15 MediumThermoFisherCat\#11415064Leibovitz's L-15 medium -Lys -ArgGIBCO Life technologiesN/A (customized)Stable isotope-coded amino acids Lys8Silantes GmbHCat\#211603902Stable isotope-coded amino acids Arg10Silantes GmbHCat\#20160390Antibiotic-Antimycotic (100X)Thermo Fisher ScientificCat\#15240062Poly-L-lysineSigma-AldrichCat\#P1274LamininSigma-AldrichCat\#L2020PuromycinSigma-AldrichCat\#P8833CycloheximideSigma-AldrichCat\#C4859AnisomycinSigma-AldrichCat\#A9789Cy5-UTPPerkinElmerCat\#NEL582001EASUPERase In RNase InhibitorAmbionCat\#AM2696FluorSaveMerck Millipore (Calbiochem)Cat\#345789-20Duolink In Situ Mounting Medium with DAPISigma-AldrichCat\#DUO82040-5MLRecombinant mouse Netrin-1R&D systemsCat\#1109-N1RNase AAmbionCat\#EN0531Rnase T1AmbionCat\#EN0541n-OctylglucosideSigma-AldrichCat\#10634425001**Critical Commercial Assays**NeuroPORTER transfection reagentSigma-AldrichCat\#NPT01Rneasy mini kitQIAGENCat\#74104SuperScript II First Strand Synthesis kitThermo Fisher ScientificCat\#18080051Quantitect SYBR Green PCR kitQIAGENCat\#204141KAPA HyperPrep kitRocheCat\#KK8503NextSeq 500/550 high output v2 kit (150 cycles)IlluminaCat\#FC-404-2002Duolink *In Situ* Detection Reagents GreenSigma-AldrichCat\#DUO92014Duolink *In Situ* PLA probe Anti-Rabbit PLUSSigma-AldrichCat\#DUO92002Duolink *In Situ* PLA probe Anti-Mouse MINUSSigma-AldrichCat\#DUO92004Click-iT Cell Reaction Buffer KitThermo Fisher ScientificCat\#10269**Deposited Data**Proteomics dataThis studyPRIDE: [PXD011032](pride:PXD011032){#intref0105}PRIDE: [PXD015574](pride:PXD015574){#interref325}RNA-sequencing dataThis studyGSE135502**Experimental Models: Organisms/Strains***Xenopus laevis*NascoCat\#LM00715, Cat\#LM00535**Oligonucleotides**Morpholino: Control MO 5′-CCTCTTACCTCAGTTA\
CAATTTATA-3′Gene toolsN/AMorpholino: Rps4x.S MO 5′-TTCTTCGGTCCGCGA\
GCCATG-3′Gene toolsN/AMorpholino: Rps4x.L MO 5′-CTTTTTCGGTCCACG\
AGCCATTTTC-3′Gene toolsN/AMorpholino: Rpl5 MO 5′- ACCTTTACGAACCCC\
ATTTTGCTCT −3′Gene toolsN/AMorpholino: Rps3a.S MO 5′- TCTTGTTCTTGCCG\
ACTGCCATC −3′Gene toolsN/AMorpholino: Rps3a.S MO 5′- GTTCTTGCCCACTGC\
CATCTTGC −3′Gene toolsN/APrimers for 18S rRNA (*Xenopus laevis*) qRT-PCR forward: 5′-GTAACCCGCTGAACCCCGTT-3′This studyN/APrimers for 18S rRNA (*Xenopus laevis*) qRT-PCR reverse: 5′-CCATCCAATCGGTAGTAGCG-3′This studyN/A5′RACE oligo 1: 5′-GGTCCACGAGCAAAGACA\
CCAGTCAA −3′This studyN/A5′RACE oligo 1^st^ PCR: 5′- GCAAAGACACCAGTCA\
ACTTGTCCAACATC −3′This studyN/A5′RACE oligo 2^nd^ PCR: 5′- AACACGCTTCAAGTGCT\
TTTTCGGTCCA −3′This studyN/A5′RACE sequencing oligo: 5′- GTGCTTTTTCGGT\
CCACGAGCAAAGAC −3′This studyN/APrimers for 18S pre-rRNA (*Xenopus laevis*) RT-PCR forward: 5′-GAGCGAGAGAGAAAGACGGA −3′This studyN/APrimers for 18S pre-rRNA (*Xenopus laevis*) RT-PCR reverse: 5′-TCTAGAGTCACCAAAGCGGC −3′This studyN/A**Recombinant DNA**Plasmid: pCS2+-Venus-Rps4x-Full lengthThis studyN/APlasmid: pCS2+-Venus-Rps4x-Del CUICThis studyN/APlasmid: pCS2+-Venus-Rps4x-Del 5′UTRThis studyN/APlasmid: pCS2+-Venus-Rps4x-Del 5′UTR-3′UTRThis studyN/APlasmid: pCS2+-Venus-Rps4x (Xenopus)This studyN/APlasmid: pCS2+-mGFP[@bib14]N/APlasmid: pCS2+-mRFP[@bib52]N/APlasmid: pCS2+-Mo resistant Rps4x del-5'UTR/mGFP dual promotorThis studyN/APlasmid: pCS2+-Mo resistant Rps4x del-CUIC/mGFP dual promotor constructThis studyN/APlasmid: pCS2+-MO resistant Rps4x/mGFP dual promotor constructThis studyN/A**Software and Algorithms**VolocityPerkinElmerVersion 6.0.1, RRID:[SCR_002668](rridsoftware:SCR_002668){#intref0110}Rv.3.2.2RRID: [SCR_001905](rridsoftware:SCR_001905){#intref0115}TopHat2v.2.0.12RRID: [SCR_013035](rridsoftware:SCR_013035){#intref0120}Cufflinksv.2.2.1RRID: [SCR_014597](rridsoftware:SCR_014597){#intref0125}HISAT2v.2.1.0RRID: [SCR_015530](rridsoftware:SCR_015530){#intref0130}HOMERv.3.0RRID: [SCR_010881](rridsoftware:SCR_010881){#intref0135}Vienna RNAv.2.4.3RRID: [SCR_008550](rridsoftware:SCR_008550){#intref0140}DAVIDv.6.8RRID: [SCR_001881](rridsoftware:SCR_001881){#intref0145}FIJI[@bib59]Version 2.0.0-rc-65/1.51w, RRID:[SCR_002285](rridsoftware:SCR_002285){#intref0150}Simple Neurite Tracer[@bib38]<https://imagej.net/Simple_Neurite_Tracer>MATLABMathworks; v. R2016bRRID:[SCR_001622](rridsoftware:SCR_001622){#intref0160}GraphPad PRISMGraphpad; v.5RRID:[SCR_002798](rridsoftware:SCR_002798){#intref0165}MaxQuantv.1.4.1.2RRID: [SCR_014485](rridsoftware:SCR_014485){#intref0170}RapidSTORM[@bib73]N/APyMOL<https://www.pymol.org2/2>RRID:[SCR_000305](rridsoftware:SCR_000305){#intref0180}**Other**RNA-seq dataset[@bib61]GEO: [GSE79352](ncbi-geo:GSE79352){#intref0185}RNA-seq dataset[@bib19]GEO: [GSM1948717](ncbi-geo:GSM1948717){#intref0190}Proteome dataset[@bib5]PRIDE: [PXD005469](pride:PXD005469){#intref0195}POSTAR2 database[@bib79]N/AMicrofluidic chambersXona MicrofluidicsCat\#SOC150Falcon Cell Culture InsertsThermo Fisher ScientificCat\#08-771-7/353102

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and request for resources and reagents should be directed to the Lead Contact, Christine E. Holt (<ceh33@cam.ac.uk>). All unique plasmids are available from the Lead Contact.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### *Xenopus laevis* Embryos {#sec4.3.1}

*Xenopus laevis* eggs were fertilized *in vitro* and embryos were raised in 0.1x Modified Barth's Saline (MBS; 8.8mM NaCl, 0.1 mM KCl, 0.24mM NaHCO~3~, 0.1 mM HEPES, 82μM MgSO~4~, 33μM Ca(NO~3~)~2~, 41μM CaCl~2~) at 14-20°C and staged according to the tables of [@bib47]. All animal experiments were approved by the University of Cambridge Ethical Review Committee in compliance with the University of Cambridge Animal Welfare Policy. This research has been regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the University of Cambridge Animal Welfare and Ethical Review Body (AWERB).

### Primary *Xenopus* Retinal Cultures {#sec4.3.2}

Eye primordia were dissected from Tricaine Methanesulfonate (MS222) (Sigma-Aldrich) anesthetized embryos of either sex at stage 35/36 and cultured on 10μg/ml poly-L-lysine (Sigma-Aldrich)- and 10μg/ml laminin (Sigma-Aldrich)-coated glass bottom dishes (MatTek) in 60% L-15 medium (ThermoFisher), 1x Antibiotic-Antimycotic (ThermoFisher) at 20°C for 24-48 hours. 10-20 eye primordia (from 5-10 embryos) were cultured per dish and, typically, 2-3 dishes were used per experimental condition for each biological replicate. Replicates in each experiment using *Xenopus laevis* in this study were obtained from different batches of embryos.

Method Details {#sec4.4}
--------------

### RNA-seq analysis of *Xenopus laevis* axons {#sec4.4.1}

We performed the axon cultures using eyes of stage 33/34-37/38 embryos of *Xenopus laevis* ([@bib47]) on a Boyden chamber device as described above at room temperature for 48hrs. To obtain the axonal transcriptome, we isolated total RNA from RGC axons separated from their cell bodies by a Boyden chamber device (1 μm pore, Falcon Cell Culture Inserts, 10289270/353102, Thermo fisher scientific) coated on both sides of the membrane with poly-L-lysine (10 μg/ml) and only on the bottom side with laminin (10 μg/ml). We cultured 500 eyes of *Xenopus laevis* embryos (stage 33/34-37/38) for each sample, yielding \< 4-5μg axonal material. Eyes were dissected out and cultured as whole eyes on the upper surface of the transfilter in 60% L15 medium containing penicillin streptomycin fungizone (GIBCO) at room temperature for 48 hours. After 48 hours, we removed the cell bodies and lysed the axons in RLT buffer (QIAGEN) containing β-mercaptoethanol. RNA was then extracted using the RNeasy Mini kit (QIAGEN) followed by in-column DNase I treatment to remove genomic DNA contamination. We then amplified cDNA using a method developed for single cell transcriptomics ([@bib66]) with minor modifications ([@bib61]). The cDNA library preparation was performed using a KAPA Hyperprep kit (Roche) and cDNA libraries were subjected to a RNA-sequencing run on Next-seq 500 instrument (Illumina) using the 150 cycles high output kit (Illumina). The sequence reads were mapped using HISAT 2 version 2.1.0, and FPKM values were estimated using Cufflinks version 2.1.1. If RP-coding mRNAs are transcribed from two homeologs, we calculated the average FPKM of homeologs. We used previously published RNA-seq data (GSM1948717) of *Xenopus laevis* whole embryos for a control.

### Plasmid Construction {#sec4.4.2}

To construct Venus reporter plasmids used in FRAP and single molecule translation imaging, Venus cDNA and 5′ / 3′ UTR of mouse Rps4x/eS4 (NM_009094) were integrated into BamHI-XbaI sites of pCS2+ (University of Michigan, Ann Arbor, Mich.). 8 nucleotides (CTCTTTCC) in the 5′ UTR were deleted in the "Del-motif" construct. To generate Rps4x-Venus fusion constructs, Venus and *X.laevis* Rps4x.S sequences were inserted into the BamHI-RcoRI sites of pCS2+. In these constructs, a CMV promoter drives the expression of 5′ UTR(Rps4x.S)-Venus-linker (Gly-Gly-Ser-Gly-Gly-Gly-Ser-Gly)-CDS (Rps4x.S, NM_001097003.1)-3′ UTR(Rps4x.S). Because frog 5′ UTR sequences of Rps4x.S in public databases could be truncated, we used a sequence of actually transcribed mRNA in frog embryos, which is obtained from a previously published RNA-seq data (GSM1948717) mapped to genome Xla.v91: 5′-cgcgctctcttcctgccagagttcagcgcgcactctttatcccggcgggaccggaaggaggaggtcttttcc-3′. To construct the plasmids for the rescue experiment of the morpholino phenotype, we replaced the β-actin cDNA of the morpholino insensitive β-actin/mGFP dual promoter construct ([@bib75]) with 5′ UTR-CDS-3′ UTR of Rps4x.S in which silent mutations (ATGGCTCGCGGACCGAAGAAGC = \> ATGGCACGGGGCCCCAAAAAAC) were introduced to avoid morpholino binding. In the "del-CUIC" rescue construct, both of the two motifs (TCTCTTCC and TCTTTTCC) in the 5′ UTR were removed.

### Axon Culture and SILAC {#sec4.4.3}

We performed the axon cultures as described above for RNA-seq analysis. Then, we treated the eyes with lysine- and arginine-free L15 (60%) medium for 1hr. After eye removal to eliminate the cell bodies, the axons were cultured in L15 depletion medium containing "heavy" amino acids (84 μg/ml \[13C6,15N4\] l-arginine, 146 μg/ml \[13C6,15N2\] l-lysine (Silantes, Germany) and Netrin-1 (600 ng/ml; R&D systems) for 3hrs. Soma removal was confirmed by absence of nuclear DAPI staining. For the preparation of control eye samples, we cultured dissected eyes in L15 depletion medium containing "heavy" amino acids at room temperature for 48hrs. Lysis of axons was performed using 500 μL Lysis buffer (9mM Tris-HCl pH 7.4, 270mM KCl, 9 mM MgCl~2~, 1% n-octylglycoside (Sigma-Aldrich),100μg/ml cycloheximide (Sigma-Aldrich), 0.5mM DTT, EDTA-free protease inhibitor cocktail (Roche) and SUPERase In RNase Inhibitor (Ambion)). Lysates were centrifuged at 16.000 g at 4°C for 15 min and the supernatant was transferred to an ice-cold 1.5ml tube. For the puromycin/RNaseA/T1 treated sample, axons were treated with 200 μM puromycin for 15min before lysis and lysates were treated with 10 μg/μl RNase A (Ambion) and 250U RNase T1 (Ambion) for 15 min at 25°C.

### Polysome Fractionation {#sec4.4.4}

For density gradient fractionation, the lysate was layered on a sucrose gradient (10%--50%) and ultracentrifugation was performed using a Beckman SW-40Ti rotor and Beckman Optima L-100 XP ultracentrifuge, with a speed of 35,000 rpm at 4°C for 160 min. Fractionations and UV absorbance profiling were carried out using Density Gradient Fractionation System (Teledyne ISCO). For sucrose cushioning, the lysate was layered on a 20% sucrose solution (20% sucrose, 10 mM Tris-HCl pH 7.4, 300 mM KCl,10 mM MgCl2), which contains a high concentration of KCl to avoid the aspecific binding of proteins to ribosomes. Then, ultracentrifugation was performed using a Beckman SW-55Ti rotor and Beckman Optima L-100 XP ultracentrifuge, with a speed of 41,000rpm at 4°C for 120 min. Proteins were precipitated from each fraction using methanol-chloroform precipitation and pellets were resuspended in 1x NuPAGE LDS sample buffer and used for western blotting as described below. RNA from each fraction was isolated as described below.

### Quantitative PCR {#sec4.4.5}

RNA from fractionated samples or from the axonal compartment of the microfluidic chambers were isolated using the RNeasy mini kit (QIAGEN) and reverse transcribed into cDNA using random hexamers and the SuperScript III First-strand synthesis kit (Thermo Fisher Scientific). Triplicate reactions for qPCR were prepared using this cDNA and the Quantitect SYBR Green PCR kit (QIAGEN) according to manufacturer's instructions. Plates were centrifuged shortly and run on a LightCycler 480 machine (Roche) using the following PCR conditions: denaturation step for 15 s at 94°C; annealing step for 30 s at 60°C; extension step for 30 s at 72°C. The following primers were used for qPCR: *18S rRNA* 5′-GTAACCCGCTGAACCCCGTT-3′ and 5′-CCATCCAATCGGTAGTAGCG-3′.

### 5′RACE and RT-PCR {#sec4.4.6}

We used 5′ RACE System for Rapid Amplification of cDNA Ends, version 2.0 (Thermo Fisher scientific) and followed. For the cDNA synthesis, we used the primer: 5′-GGTCCACGAGCAAAGACACCAGTCAA-3′. For the 1st PCR amplification, we used a reverse primer: 5′-GCAAAGACACCAGTCAACTTGTCCAACATC-3′. For the 2nd PCR amplification, we used a reverse primer: 5′-AACACGCTTCAAGTGCTTTTTCGGTCCA-3′.

We purified the amplified product from gel after the electrophoresis by using Wizard SV Gel and PCR Clean-Up System (Promega) and performed the direct sequence of the purified DNA using the primer: 5′-GTGCTTTTTCGGTCCACGAGCAAAGAC-3′. For the amplification of pre-rRNA, the following primers were used: *18S-5end-F* 5′-GAGCGAGAGAGAAAGACGGA-3′ and *18S-5end-R* 5′- TCTAGAGTCACCAAAGCGGC-3′.

PCR amplifications were performed using Ex Taq HS (Takara).

### Axonal Morpholino Delivery *in vitro* {#sec4.4.7}

Modified microfluidic chambers (Xona microfluidics, SOC150) were pre-coated with poly-L-lysine (10 μg/ml) and laminin (10 μg/ml). Eyes dissected from stage 30-33 *X. laevis* embryos were plated in the open chamber of SOC150. RGC axons were grown in 60% L15 medium containing μg/ul penicillin streptomycin fungizone at room temperature for 48 hr. For the morpholino introduction, we prepared two solutions: diluted transfection reagent (2 μL NeuroPORTER Transfection Reagent (Sigma-Aldrich) with 5.5 μL L15 (60%)) and morpholino solution (2.5 μL of 1mM morpholino oligonucleotide (mixture of 5′-CTTTTTCGGTCCACGAGCCATTTTC-3′ (against Rps4x.L) and 5′-TTCTTCGGTCCGCGAGCCATG-3′ (against Rps4x.S) or 5′-ACCTTTACGAACCCCATTTTGCTCT-3′ (against Rpl5) or a mixture of 5′-TCTTGTTCTTGCCGACTGCCATC-3′ (against Rps3a.S) and 5′-GTTCTTGCCCACTGCCATCTTGC-3′ (against Rps3a.L) with 5 μL L15 (60%)). We mixed 7.5 μL morpholino solution with 7.5 μL diluted transfection reagent and incubated the mixture at room temperature for 5 min. We added the 15 μL of mixture directly to 200 μL of the medium present in the axon chamber and incubated it at room temperature for 18-24 hours.

### Immunohistochemistry {#sec4.4.8}

Microfluidic chamber cultures were treated with 600ng/ml Netrin-1 (R&D systems) for 20 minutes and then fixed after detaching microfluidic chambers from the glass bottom dishes in 2% formaldehyde/7,5% sucrose in PBS for 20 min at 20°C. The fixed cultures were steamed for 10min in sodium citrate buffer for antigen retrieval in case of ribosomal protein staining. Subsequently, they were permeabilized for 3-5 min in 0.1% Triton X-100 in PBS and blocked with 5% heat-inactivated goat serum in PBS for 45 min at 20°C. Primary antibodies were incubated overnight at 4°C, followed by Alexa Fluor-conjugated secondary antibodies for 45 min at 20°C in the dark. Cultures were mounted in FluorSave (Calbiochem).

Antibodies were used at the following dilutions. Primary antibodies: rabbit anti-Rps4x (Proteintech, Cat\#14799-1-AP; RRID: [AB_2238567](nif-antibody:AB_2238567){#intref0205}, 1:200), 1:200 rabbit anti-Rpl17 (Proteintech, Cat\#14121-1-AP; RRID: [AB_2253985](nif-antibody:AB_2253985){#intref0210}, 1:200), rabbit-anti-Rps3a (Proteintech, Cat\#14123-1-AP; RRID: [AB_2253921](nif-antibody:AB_2253921){#intref0215}). Secondary antibodies: goat anti-rabbit Alexa Fluor 594 (Abcam, Cat\#ab150080; RRID: [AB_2650602](nif-antibody:AB_2650602){#intref0220}, 1:1000). Culture medium in the axonal compartment was replaced with 200 μL of culture medium containing 600ng/ml Netrin-1 and 10μg/ml puromycin (Sigma). After 20min, the axonal compartment was washed once with fresh culture medium before detaching the microfluidic chamber from the dish. The retinal culture was immediately fixed in 2% formaldehyde/7,5% sucrose in PBS for 20 min at 20°C, permeabilized for 3-5 min in 0.1% Triton X-100 in PBS, blocked with 5% heat-inactivated goat serum in PBS for 30 min at 20°C and then labeled with Alexa Fluor 647-conjugated mouse anti-puromycin antibody (Millipore, Cat\#MABE343-AF647, 1:250) overnight at 4°C. Cultures were mounted in FluorSave (Calbiochem).

Transfilters from Boyden chambers were immunostained after eye removal using mouse-anti-neurofilament A (Developmental Studies Hybridoma Bank, Cat\#3A10; RRID: [AB_531874](nif-antibody:AB_531874){#intref0225}) and DAPI, as previously described ([@bib5]).

For qIF or immunostaining on regular *Xenopus* retinal cultures ([Figures 2](#fig2){ref-type="fig"}D, 2E, [5](#fig5){ref-type="fig"}F, [S2](#mmc1){ref-type="supplementary-material"}D, and S2E), cultures were treated with or without 50 μM cycloheximide (Sigma) and 600ng/ml Netrin-1 for 5 minutes before fixation in 2% formaldehyde/7,5% sucrose in PBS for 20 min at 20°C. For Rps12 qIF, 600ng/ml Netrin-1 was added for 30 minutes before fixation. The fixed cultures were steamed for 10min in sodium citrate buffer for antigen retrieval in case of ribosomal protein and Npm1 staining. For Abce1 and Gtpbp4 immunostaining, methanol fixation was used. The cultures were then permeabilized and blocked as described above and stained with primary antibodies were incubated overnight at 4°C, followed by Alexa Fluor-conjugated secondary antibodies for 45 min at 20°C in the dark. Cultures were mounted in FluorSave (Calbiochem). The following antibodies were used: rabbit anti-Rps14 (Abcam, Cat\#ab174661; 1:200), rabbit anti-Rps4x (Proteintech, Cat\#14799-1-AP; RRID: [AB_2238567](nif-antibody:AB_2238567){#intref0230}, 1:200), rabbit anti-Rpl39 (Abcam, Cat\#ab74740; RRID: [AB_1524345](nif-antibody:AB_1524345){#intref0235}, 1:200), rabbit anti-Rps12 (Proteintech, Cat\#16490-1-AP; RRID: [AB_2146233](nif-antibody:AB_2146233){#intref0240}, 1:200), rabbit anti-Abce1 (Abcam, Cat\#ab32270; RRID: [AB_722514](nif-antibody:AB_722514){#intref0245}, 1:200), rabbit anti-Gtpbp4 (Abcam, Cat\#ab92342; RRID: [AB_2049721](nif-antibody:AB_2049721){#intref0250}, 1:200), mouse anti-Npm1 (Origene, Cat\#BM5524; RRID: [AB_1008764](nif-antibody:AB_1008764){#intref0255}, 1:200), Secondary antibodies: goat anti-rabbit Alexa Fluor 594 (Abcam, Cat\#ab150080; RRID: [AB_2650602](nif-antibody:AB_2650602){#intref0260}, 1:1000), goat anti-mouse Alexa Fluor 568 (Abcam, Cat\#ab150117; RRID: [AB_2688012](nif-antibody:AB_2688012){#intref0265}, 1:1000).

Randomly selected non-collapsed growth cones were imaged at 60x on a Nikon Eclipse TE2000-U inverted microscope equipped with an EMCCD camera. For Abce1, Gtpbp4 and Npm1 immunostaining, imaging was carried out at 100x on a Perkin Elmer Spinning Disk UltraVIEW ERS, Olympus IX81 inverted microscope. Exposure time was kept constant and below gray-scale pixel saturation.

### Blastomere Microinjection {#sec4.4.9}

Embryos were microinjected with Cy5-UTP at 100 μM in a total volume of 5nl (PerkinElmer) into both of the dorsal blastomeres at 4- or 8-cell stage ([@bib75]). Embryos were first de-jellied in 2% Cysteine (Sigma-Aldrich) in 1x MBS (pH 8.0), washed 3 times in 0.1x MBS and aligned on a grid in 4% Ficoll (Sigma-Aldrich) in 0.1x MBS with 1X antibiotic-antimyotic (Thermo Fisher Scientific). Injections were performed using glass capillary needles (outer diameter: 1.0mm; inner diameter: 0.5mm; Harvard Apparatus) and a pressurized microinjector (Picospritzer, General Valve).

### FUNCAT-rRNA Proximity Ligation Assay {#sec4.4.10}

*Xenopus* retinal explants from stage 35-36 embryos were first cultured as described above in complete 60% L-15 medium (GIBCO, Thermo Fisher Scientific) for 24 hours, which was then replaced with methionine-free L-15 medium (GIBCO, Thermo Fisher Scientific) for a further 12 hours. After 11 hours, 200μM anisomycin (Sigma-Aldrich) was added into the culture for the +anisomycin condition and an equal concentration and volume of DMSO (Sigma-Aldrich) was added to all other conditions. After 1 hour, axons were severed from the explants to exclude axonal transport of nascent peptides synthesized in the cell bodies, immediately followed by the addition of 1mM AHA (Thermo Fisher Scientific) and 600ng/ml Netrin-1 (R&D) in the +AHA +Netrin-1 and +anisomycin conditions, 1mM AHA in the +AHA -Netrin condition, or an equal concentration and volume of DMSO (as in the AHA stock solution) and 600ng/ml Netrin-1 in the -AHA condition. After 45 minutes, 200μM puromycin (Sigma-Aldrich) was mixed into the AHA- and/or Netrin-1-containing medium for a further 15 min incubation to release all synthesizing polypeptides from axonal ribosomes. After washing once with PBS to remove unincorporated AHA, the cultures were fixed in 2% formaldehyde/7.5% sucrose in PBS for 20 min at 20°C and permeabilized for 5 min in 0.1% Triton X-100 in PBS. The Click Chemistry reaction was performed according to the manufacturer's protocol (Click-iT Cell Reaction Buffer Kit, Thermo Fisher Scientific) starting with washing the fixed cultures with 2% BSA in PBS (w/v) and incubating the culture for 30 min at 20°C in freshly prepared Click-iT reaction cocktail containing the Click-iT cell reaction buffer, the buffer additive, CuSO~4~ and 5μM biotin-alkyne (Thermo Fisher Scientific). The cultures were then washed once in 2% BSA in PBS (w/v) and blocked with 5% heat-inactivated goat serum in PBS for 30 min at 20°C. A mouse anti-ribosomal RNA (Y10B) antibody (1:100, Abcam, Cat\#ab171119) and a rabbit anti-biotin antibody (1:200, Cell Signaling, Cat\#5597, RRID: [AB_10828011](nif-antibody:AB_10828011){#intref0270}) were incubated overnight at 4°C. The proximity ligation assay was carried out according to the manufacturer's protocol (Duolink, Sigma-Aldrich) with minor modifications. Dishes were washed twice for 5 minutes with 0.002% Triton X-100 in PBS and incubated with anti-rabbit (+) and anti-mouse (-) PLA probes for 1 hour at 37°C, with ligase for 30 min at 37°C and with the polymerase mix with green fluorescence for 100 min at 37°C. The samples were subsequently mounted with mounting medium (Duolink, Sigma-Aldrich) and imaged using an Olympus IX81 inverted microscope fitted with a PerkinElmer Spinning Disk UltraVIEW VoX using a 60x silicone oil objective (1.4 N.A., Olympus), and an ORCA-Flash4.0 V2 CMOS camera (Hamamatsu). Volocity 6.3.0 software (PerkinElmer) was used for acquisition. The number of discrete fluorescent puncta within a randomly chosen 50μm axon segment in each image was counted using Volocity software.

### Fluorescence Recovery After Photobleaching {#sec4.4.11}

Retinal cultures for FRAP assays were obtained from eyes of stage 33/34 embryos expressing one of the four Venus constructs ([Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}F) or Venus-Rps4x / Venus-only for Cy5-UTP colocalization experiments ([Figures 4](#fig4){ref-type="fig"}D, 4E, and [S4](#mmc1){ref-type="supplementary-material"}). These constructs were introduced by eye-targeted electroporation at stage 26 as described in previous studies ([@bib21], [@bib75]). 1μg/μl Venus construct ([Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}F) or 1.5μg/μl of Venus-Rps4x (Venus only) with 100uM Cy5-UTP ([Figures 4](#fig4){ref-type="fig"}D, 4E, and [S4](#mmc1){ref-type="supplementary-material"}) were injected for the electroporation.

FRAP imaging was performed on an Olympus IX81 inverted microscope equipped with a PerkinElmer Spinning Disk UltraVIEW VoX and a 60x (NA, 1.30) Olympus silicone oil immersion objective. Images were acquired with an ORCA-Flash4.0 V2 CMOS camera (Hamamatsu) using Volocity software (PerkinElmer). Photobleaching was performed using an UltraVIEW PhotoKinesis device (PerkinElmer). Photobleaching was performed at 85%--90% laser power (488 nm laser line) with 20--30 bleach cycles.

For the FRAP experiment imaging axons expressing Rps4x UTR-containing Venus constructs or the Venus-only construct indicated in [Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}F, axons of the 24h retinal cultures were severed from the eye and 600ng/ml Netrin-1 was added into the culture. A randomly selected fluorescent growth cone of a severed axon then proceeded to the photobleaching step using 488 nm laser line, immediately after pre-photobleaching fluorescent and phase contrast images were acquired. The photobleached area was manually defined so that growth cones and \> 50 μm of the axon shaft were bleached (thus reducing likelihood of fluorescence recovery resulting from Venus diffusion from unbleached areas of the axon shaft). In anisomycin-treated condition, 24h cultures were incubated with 100μM anisomycin for 20 min before severing the axons. Time-lapse post-photobleaching images were captured at 1 min intervals using a 488 nm laser line at 20% laser power, together with phase contrast images for the corresponding time point. Exposure time was adjusted to avoid pixel saturation.

For the FRAP experiment imaging axons expressing Cy5-UTP and Venus-Rps4x fusion construct or Venus-only construct shown in [Figures 4](#fig4){ref-type="fig"}D and [S4](#mmc1){ref-type="supplementary-material"}, axons of the 24h retinal cultures were severed from the eye and 600ng/ml Netrin-1 was added into the culture. A 30 s pre-photobleaching movie at maximum speed of a randomly selected Cy5- and Venus-positive 50 μm axon segment was taken, followed by photobleaching of the Venus fluorescence using a 488 nm laser line. 30 s post-photobleaching fluorescent and phase contrast movies at maximum speed were acquired at 0 min, 5 min and 10 min after the completion of photobleaching. Exposure time was adjusted to avoid pixel saturation.

### Single Molecule Translation Imaging {#sec4.4.12}

Single molecule translation imaging was done as previously described([@bib64], [@bib67]). Embryos at stage 26 were electroporated with plasmids expressing Rps4x UTR-containing Venus constructs or the Venus-only and left in 0.1X MBS to continue to develop. Venus-expressing eyes from electroporated embryos at stage 34 were dissected and cultured. After 24 hours, a non-collapsed fluorescent growth cone was randomly selected and, prior to the bleaching step, imaged with low irradiance (\< 2W/cm^2^) in both fluorescence and bright field mode to generate an outline image. The growth cone was then photobleached for 10-30 s with an irradiance of 1.5 kW/cm2 to eliminate the fluorescence. A reduced laser intensity of 0.3 kW/cm2 was used to ensure survival of the axons while simultaneously bleaching newly synthesized Venus proteins. The flash-like recovery of Venus fluorescence recorded with an exposure time of 200 ms for 180 s. After that another bright field image was taken to check for survival. Retracted growth cones were excluded from analysis. In Netrin-1-stimulated conditions, 600ng/ml of Netrin-1 was bath applied immediately before the photobleaching step. All imaging steps were performed under epifluorescence illumination. An EM gain of 200 was used on the EMCCD camera to ensure single molecule sensitivity. The field of illumination was twice the size of the imaged field of view to bleach diffusing or transported fluorescent proteins from outside the growth cone before entering the field of view. Imaging was performed on a custom-made inverted single-molecule fluorescence microscope built around a commercial microscope frame (Olympus IX73). The illumination laser wavelength was at 488nm (Coherent Sapphire) for excitation of the YFP derivate Venus in combination with a 525/645-emission filter (Semrock) and a dichroic beam splitter (Chroma ZT405/488/561/640rpc). The laser beam was circularly polarized to excite fluorescent proteins homogeneously regardless of their orientation. The microscope was equipped with an EM-CCD camera (Andor iXon Ultra 897) with effective pixel size on the sample of 118 nm. A 100x NA = 1.49 oil immersion TIRF objective (Olympus) was used.

### *In Vivo* Knockdown and Imaging {#sec4.4.13}

Targeted eye and tectal electroporations were performed as previously described ([@bib21], [@bib75]). Stage 28 embryos were anesthetized in 0.4mg/ml MS222 in 1X MBS. The retinal primordium was injected with electroporation mixture, followed by electric pulses of 50ms duration at 1000ms intervals, delivered at 18V (please refer to the list below for the mixture and the number of electric pulses delivered for each experiment). The embryos were recovered and raised in 0.1X MBS until the desired embryonic stage for experiment.1)Mature axon visualization ([Figures 7](#fig7){ref-type="fig"}B--7D and [S7](#mmc1){ref-type="supplementary-material"}): 1μg/μl of pCS2+mGFP (or 1μg/μl of pCS2+mGFP/MO resistant Rps4x rescue dual promoter construct cDNA for rescue experiments), 0.5mM control/Rps4x MO; 1 pulse.2)Axon branching dynamics ([Figures 7](#fig7){ref-type="fig"}E--7G and [S7](#mmc1){ref-type="supplementary-material"}): 1μg/μl of pCS2+mGFP or 1μg/μl of pCS2+mRFP, 0.5mM control/Rps4x MO; 4 pulses.

For tectal electroporation ([Figures 7](#fig7){ref-type="fig"} and [S7](#mmc1){ref-type="supplementary-material"}), the lateral surface of the hemisphere of the brain contralateral to the eye labeled with mRFP (electroporated at Stage 28 as described above) was exposed by careful removal of overlying eye and epidermis. 8X 18V electric pulses of 50ms duration at 1000ms intervals were delivered immediately after the 1mM control/Rps4x MO was locally ejected at the vicinity of the target area. The procedure was repeated once to ensure efficient delivery of the MO ([@bib75]). Embryos were lightly anaesthetized with 0.4mg/ml MS222 in 1xMBS. The lateral surface of the brain contralateral to the electroporated eye was exposed by carefully removing the overlying epidermis and the contralateral eye. The electroporated eyes were also surgically removed to prevent somal contribution of proteins in [Figures 7](#fig7){ref-type="fig"}F and [S7](#mmc1){ref-type="supplementary-material"}. Embryos were mounted in an oxygenated chamber created with Permanox slides (Sigma-Aldrich) and Gene Frame (ThermoFisher) and bathed in 1xMBS with 0.1mg/ml MS222, for visualization with fluorescence microscopy. Imaging was performed using 40X (NA 1.25) or 60X UPLSAPO objectives (NA 1.3) with a PerkinElmer Spinning Disk UltraVIEW ERS, Olympus IX81 inverted spinning disk confocal microscope. Z stack intervals of 1-2μm were employed for acquiring images with Volocity (PerkinElmer).

### Western Blotting {#sec4.4.14}

Proteins were resolved by SDS-PAGE on NuPage 4%--12% Bis-Tris gels (Invitrogen) and transferred to a nitrocellulose membrane (Bio-Rad). The blots were blocked in blocking buffer (5% milk in TBS-T) and then incubated with primary antibodies in blocking buffer overnight at 4°C. After 3 washes (5 minutes each) with TBS-T, the blots were incubated with HRP-conjugated secondary antibodies in blocking buffer for 1 hour at RT, washed again for 3 times (5 minutes each) in TBS-T and developed using ECL-based detection (Pierce ECL plus, Thermo Scientific). The following primary antibodies were used for western blot analysis: mouse anti-Rpl19 (Abcam, Cat\#ab58328; RRID: [AB_945305](nif-antibody:AB_945305){#intref0275}, 1:1000), mouse anti-Rps23 (Abcam, Cat\#ab57644; RRID: [AB_945314](nif-antibody:AB_945314){#intref0280}, 1:1000), rabbit anti-Rps4X (Proteintech, Cat\#14799-1-AP; RRID: [AB_2238567](nif-antibody:AB_2238567){#intref0285}, 1:1000), rabbit β-catenin (Sigma-Aldrich, Cat\#C2206; RRID: [AB_476831](nif-antibody:AB_476831){#intref0290}, 1:8000) and rabbit anti-β-actin (Abcam, Cat\#ab8227; RRID: [AB_2305186](nif-antibody:AB_2305186){#intref0295}).

### Mass Spectrometry {#sec4.4.15}

1D gel bands were transferred into a 96-well PCR plate. The bands were cut into 1mm^2^ pieces, de-stained, reduced (DTT) and alkylated (iodoacetamide) and subjected to enzymatic digestion with chymotrypsin overnight at 37°C. After digestion, the supernatant was pipetted into a sample vial and loaded onto an autosampler for automated LC-MS/MS analysis. LC-MS/MS experiments were performed using a Dionex Ultimate 3000 RSLC nanoUPLC (Thermo Fisher Scientific Inc., Waltham, MA, USA) system and a Q Exactive Orbitrap mass spectrometer (Thermo Fisher Scientific Inc, Waltham, MA, USA). Separation of peptides was performed by reverse-phase chromatography at a flow rate of 300nL/min and a Thermo Scientific reverse-phase nano Easy-spray column (Thermo Scientific PepMap C18, 2 μm particle size, 100A pore size, 75 μm i.d. x 50cm length). Peptides were loaded onto a pre-column (Thermo Scientific PepMap 100 C18, 5 μm particle size, 100A pore size, 300 μm i.d. x 5mm length) from the Ultimate 3000 autosampler with 0.1% formic acid for 3 minutes at a flow rate of 10 μL/min. After this period, the column valve was switched to allow elution of peptides from the pre-column onto the analytical column. Solvent A was water + 0.1% formic acid and solvent B was 80% acetonitrile, 20% water + 0.1% formic acid. The linear gradient employed was 2%--40% B in 30 minutes. The LC eluant was sprayed into the mass spectrometer by means of an Easy-Spray source (Thermo Fisher Scientific Inc.). All m/z values of eluting ions were measured in an Orbitrap mass analyzer, set at a resolution of 70000 and was scanned between m/z 380-1500. Data-dependent scans (Top 20) were employed to automatically isolate and generate fragment ions by higher energy collisional dissociation (HCD, NCE:25%) in the HCD collision cell and measurement of the resulting fragment ions was performed in the Orbitrap analyzer, set at a resolution of 17500. Singly charged ions and ions with unassigned charge states were excluded from being selected for MS/MS and a dynamic exclusion window of 20 s was employed. For the label-free quantification of proteins, peptide identification and relative quantification was carried out in Proteome Discoverer version 2.3. A standard label free quantification workflow was utilized with the Mascot search algorithm, against a *Xenopus laevis* proteins downloaded from Xenbase. The search parameters included: trypsin as the proteolytic enzyme, with maximum of two missed cleavages; variable oxidation modification of methionine, and deamidation of asparagine and glutamine; fixed carbamidomethylation modification of cysteine; precursor and fragment mass tolerances of 20 ppm and 0.1 Da respectively. The false discovery rate (FDR) was set at \< 1% with two peptide matches to proteins considered as reliable. For the analysis of SILAC labeled proteins, we used Maxquant in addition to Proteome Discoverer since it is the most commonly used software for SILAC analysis. Raw data were processed using Maxquant (version 1.6.1.0) ([@bib12]) with default settings. MS/MS spectra were searched against the *X. laevis* protein sequences from Xenbase (xlaevisProtein.fasta). Enzyme specificity was set to trypsin/P, allowing a maximum of two missed cleavages. The minimal peptide length allowed was set to seven amino acids. Global false discovery rates for peptide and protein identification were set to 1%. The match-between runs and re-quantify options were enabled. To avoid false positives, we analyzed only those RPs where more than two labeled peptides were detected by the software or if the MS spectrum of the detected labeled peptides showed clear peaks at the expected m/z value.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Statistics {#sec4.5.1}

The n number for each experiment, details of statistical analysis and software are described in the figure legends or main text. Statistical analyses used in this study include one-way ANOVA, Welch's t test, Mann-Whitney U test, Kolmogorov--Smirnov test and Fisher's exact Test. Statistical significance is defined as, n.s., not significant, ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Statistical analysis was performed using R version 3.2.2 or Prism (GraphPad).

### Bioinformatics Analysis {#sec4.5.2}

We analyzed the developmental change of level of all mRNAs translated in the mouse RGC axons in dataset (GSE79352). The sequence reads were mapped to the mouse genome (mm10) using TopHat 2 version 2.0.12 with default settings, except for the "--read- realign- edit-dist 0" option. Transcript assembly and estimation of FPKM (Fragments Per Kilobase of transcript per Million fragments sequenced) values were performed using Cufflinks version 2.2.1. For RNA-seq analysis of frog RGC axons, the sequence reads were mapped to the *X. laevis* v9.2 genome (Xenbase) using HISAT2 2.1.0 with default settings. Transcript assembly and estimation of FPKM (Fragments Per Kilobase of transcript per Million fragments sequenced) values were performed using Cufflinks version 2.1.1. For the GO enrichment analysis, we only analyzed genes showing FPKM \> 1 in both of two replicates. For analysis of the pSILAC-SP3 results, we extracted all proteins that show a significant change (FDR \< 0.01) by stimulation (5min or 30min) of Netrin-1. We performed a GO enrichment analysis using DAVID 6.8 with default settings for BP-direct, MF-direct and CC-direct categories and used all detected proteins as the background of the enrichment calculation. For the ribosome structure analysis, we used the PyMOL function InterfaceResidues (<https://pymolwiki.org/index.php/Main_Page>) to know the interface residues of RPs with rRNAs. We analyzed the structure of human 80S ribosome (6ek0) published previously ([@bib45]). For the small ribosomal subunit proteins, we analyzed interface residues between RPs and 18S rRNA. For the large ribosomal subunit proteins, we analyzed the interface residues of RPs with 5S, 5.8S and 28S rRNAs.

### Motif Analysis {#sec4.5.3}

All sequences of mouse cDNAs were retrieved from BioMart at Ensembl (GRCm38, ensemble Genes 91). *De novo* motif analysis was performed using HOMER version 3.0 with custom FASTA files containing all 5′ UTR sequences of mouse RP-coding cDNAs. For the analysis of CUIC-containing genes, we selected all genes whose mRNA contains the 8-mer nucleotides (T/C)(T/C)(T/C)(T/C)TT(T/C)C located less than 100nt upstream of the initiation codon. The secondary structure analysis of UTRs was performed using performed using RNAfold in the ViennaRNA package version 2.4.3 with default settings. The conservation among species of all CUIC-containing RP mRNAs was calculated from phastCons60way.UCSC.mm10. For the analysis of proteins binding the CUIC region, we used Human RBP binding sites data downloaded from the POSTAR2 database ([@bib79]). To visualize the binding sites of EIF components, we created custom tracks on the UCSC genome browser.

### Quantification of Immunofluorescence {#sec4.5.4}

For quantitation of fluorescence intensity, the growth cone outline was traced on the phase contrast image using Volocity version 6.0.1 (PerkinElmer), then superimposed on the fluorescent image. The software calculated the fluorescent intensity within the growth cone, giving a measurement of pixel intensity per unit area. The growth cone outline was then placed in an adjacent area clear of cellular material to record the background fluorescent intensity. This reading was subtracted from the growth cone reading, yielding the background-corrected intensity.

### FRAP analysis {#sec4.5.5}

Quantification of fluorescence intensity was performed using Volocity software (PerkinElmer). At each time point, the outline of the growth cone was traced using phase contrast images. Mean gray values from the 488-channel were subsequently calculated as mean pixel intensity per unit area within the specified region of interest (ROI). This ROI was then placed in an adjacent area clear of cellular material to record the background fluorescent intensity. This reading was subtracted from the growth cone reading, yielding the background-corrected intensity. Unhealthy axons exhibiting signs of photo-toxicity after FRAP (characterized by blebbing, growth cone collapse and/or retraction) were excluded from analysis. In addition, only growth cones of axons extending more than 100 μm from the eye explant were quantified to reduce effects of somal diffusion. Relative fluorescent recovery (R) at each time point was calculated by the formula: Rx = (Ix -- Ipost) / (Ipre -- Ipost). Where, Ix = normalized fluorescent intensity of the growth cone ROI at time point 'x', Ipre = normalized fluorescent intensity before photobleaching and Ipost = normalized fluorescent intensity immediately after photobleaching (t = 0mins). Significance was tested using a two-way ANOVA. Colocalization analysis between Cy5-RNA granules and Venus-Rps4x (N = 8 axons) or Venus (N = 12 axons) in [Figure 4](#fig4){ref-type="fig"}E was performed on the first image of a 30 s movie taken 10min post-photobleaching. In each image, a 5um axon segment containing Cy5-RNA granules and recovered Venus-Rps4x or Venus signal was chosen and the Pearson's correlation coefficient between Cy5 and Venus channels within the selected area was measured by Volocity software.

### Single Molecule Translation Imaging Analysis {#sec4.5.6}

Translation event counting was performed by manual counting supplemented with the previously reported software-assisted automated event detection([@bib64]), where localizations of individual protein translation events were retrieved using maximum likelihood estimation with a Gaussian model fit via the software package rapidSTORM. A threshold of ∼6700 ADC, corresponding to ∼500 photons per localization, was applied to filter out noise and non-Venus blinking events. This threshold was found by manual selection of Venus flashes and determination of the "average" photon budget of a single emitting Venus molecule. The tracking option of rapidSTORM was used to recombine photons emanating from the same Venus protein over multiple frames. All events in a small area around the growth cones were included for analysis due to the high mobility of filopodia. Results are normalized to the growth cone area, thus given as event/s/μm^2^.

### Branching Analysis {#sec4.5.7}

A filopodium was defined as a protrusion with length \< 5 μm while a branch was defined as a protrusion with length \> 5 μm ([@bib20], [@bib28], [@bib33], [@bib75]). Data were analyzed in PRISM 7 (GraphPad). 'n' represents the number of axons. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, \#p \< 0.05, \#\#p \< 0.01, \#\#\#p \< 0.001. Details of statistic results such as p values, degree of freedom, and t/F values are presented in the figure legends. For axon arbor analysis, 3D projection of axon arbors acquired at 40X were semi-automatically traced through the z axis using the Simple Neurite Tracer plugin ([@bib38]) in Fiji. The resulting traces were then analyzed for the number and the length of axon branches as well as the Axon Complexity Index (ACI) ([@bib40]). These measured parameters were compared using one-way ANOVA with the Two-stage step-up method of Benjamini, Krieger and Yekutieli multiple comparisons test. Cumulative distribution curves of total branch number represent least-squares fits to a Gaussian function and were compared using Extra sum-of-squares F test. The proportions of simple (ACI \< 1.4) and complex (ACI ≥ 1.4) arbors in different groups were compared using Fisher's exact test ([@bib20]). For analysis of branching dynamics, the numbers of protrusions added and removed were counted on the terminal 50 μm of mGFP/mRFP-labeled RGC axons for 10 min (imaged at an interval of 30 s) ([@bib75]). The addition and removal of protrusions were then compared statistically. A paired t test was used for intragroup comparison and unpaired t test was used for intergroup comparisons.

### Western Blot Analysis {#sec4.5.8}

Developed films from western blot detection were scanned and imported into FIJI. The color was inverted and the background corrected signals for Rps4x and β-catenin were measured. Measured Rps4x levels were then normalized to β-catenin to obtain a ratiometric readout. A paired t test was used to assess differences in Rps4X protein levels between control MO and Rps4X MO samples (n = 3 independent experiments).

Data and Software Availability {#sec4.6}
------------------------------

The accession numbers for the mass spectrometry proteomics data reported in this paper are PRIDE: [PXD011032](pride:PXD011032){#interref315} and PRIDE: [PXD015574](pride:PXD015574){#interref320}. The accession number for the RNA-seq data reported in this paper is GEO: [GSE135502](ncbi-geo:GSE135502){#intref0305}.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S7Table S1. CUIC Genes, Related to Figure 1Table S2. Regulated Protein Synthesis, Related to Figure 2Table S3. Enriched GOs, Related to Figure 2Document S2. Article plus Supplemental Information

We thank J.K. Mooslehner for technical assistance. We also thank Mike Deery for invaluable expertise and the MS/MS analysis and Jeroen Krijgsveld and Christian Frese for helpful discussions. We are grateful to Simone Pellegrino and Julie Aspden for useful PyMOL software discussions, Caia Duncan for assistance with polysome fractionations, and Erin Schuman's group for helpful discussions on ribosome purification. This work was supported by Wellcome Trust grants 085314/Z/08/Z and 203249/Z/16/Z to C.E.H. and 100329/Z/12/Z to W.A.H.; European Research Council Advanced Grant (322817) to C.E.H.; Champalimaud Vision Award to C.E.H.; and the Netherlands Organization for Scientific Research (NWO Rubicon 019.161LW.033) to M.K. C.F.K. acknowledges funding from the UK Engineering and Physical Sciences Research Council (EPSRC) (grants EP/L015889/1 and EP/H018301/1); the Wellcome Trust (grants 3-3249/Z/16/Z and 089703/Z/09/Z); the UK Medical Research Council (MRC) (grants MR/K015850/1 and MR/K02292X/1); and Infinitus (China).

Author Contributions {#sec5}
====================

T.S. and C.E.H. designed the experiments. T.S. wrote the manuscript with support from M.K., C.E.H., W.A.H., H.H.-W.W., and R.C. H.H.-W.W. performed the *in vivo* knockdown and branching analysis. J.Q.L. performed FRAP. J.Q.L., F.W.v.T., F.S., and C.F.K. performed the single-molecule translation imaging. J.Q.L. performed the FUNCAT-rRNA proximity ligation assay. J.Q.L., T.S., M.K., and R.C. performed the *in vitro* knockdown. T.S., M.K., J.-M.C., A.D., and R.C. carried out the *in vitro* retinal cultures and SILAC. M.K., T.S., J.d.F.N., and M.C. performed the fractionation/cushioning of the axon samples. R.C. and H.J. analyzed Netrin-1-induced axonal translation. J.Q.L., M.K., and R.C. performed the immunostaining. T.S., M.K., and J.S. performed the qRT-PCR. T.S. performed the 5′ RACE. M.K., T.S., J.Q.L., and R.C. performed the biochemical experiments. T.S. performed the bioinformatics analysis. T.S. and C.E.H. supervised the project.

Declaration of Interests {#sec6}
========================

The authors declare no competing interests.

Supplemental Information can be found online at <https://doi.org/10.1016/j.celrep.2019.11.025>.

[^1]: These authors contributed equally

[^2]: Present address: Department of Biology, Cell Biology, Utrecht University, Utrecht, the Netherlands

[^3]: Present address: Centre of Research in Neuroscience, Brain Repair and Integrative Neuroscience Programme, Department of Neurology and Neurosurgery, The Research Institute of the McGill University Health Centre, Montreal General Hospital, Montréal, QC H3A 2B4, Canada

[^4]: Present address: Department of Physics and Technology, UiT The Arctic University of Norway, Klokkargårdsbakken 35, 9019 Tromsø, Norway

[^5]: Present address: Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy

[^6]: Present address: Grenoble Institut des Neurosciences, Bâtiment Edmond J. Safra, Chemin Fortuné Ferrini, Site Santé, 38706 La Tronche Cedex, France

[^7]: Present address: Department of Anatomy, Brain Research Institute, and Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul 03722, Republic of Korea

[^8]: Lead Contact
